Johnson & Johnson MedTech, the global leader in heart recovery, is proud to celebrate the inaugural National Heart Recovery ...

J&J's Varipulse PFA catheter recall investigation found the number of ablations, stacked ablations and ablation location may ...

Stock market investors have enjoyed strong annual returns over the past two years, but analysts caution that 2025 may not ...

Johnson & Johnson — leaders in healthcare innovation, where treatments are smarter and less invasive, and solutions are personal ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

Also Read: Johnson & Johnson’s MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst Monday’s Financial Times report, citing sources, indicates that Cerenovus ...

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...

J&J said it found no immediate procedure-related causes from the atrial fibrillation therapy but that risks can escalate if a ...

Here is a sneak peek into how three MedTech stocks, GKOS, ITGR and AMN, are expected to fare in their quarterly results, ...